Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of SC vs IV Ceftriaxone in Healthy Adults
NCT02561442Phase 3Completed
- Sponsor
- scPharmaceuticals Inc.
- Start
- Oct 2015
- Primary completion
- Dec 2015
- Modality
- Reversible Covalent Inhibitors
01
Overview
A Phase 3 trial of ceftriaxone in bacterial infection, sponsored by scPharmaceuticals Inc.. Started Oct 2015; status: completed.
02
Drugs
ceftriaxone
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT02561442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02561442.